On Invalid Date, Kamada (NASDAQ: KMDA) reported Q4 2022 earnings per share (EPS) of $0.07, up 163.64% year over year. Total Kamada earnings for the quarter were $2.94 million. In the same quarter last year, Kamada's earnings per share (EPS) was -$0.11.
On Invalid Date, Kamada (NASDAQ: KMDA) reported Q4 2022 revenue of $45.44 million up 44.39% year over year. In the same quarter last year, Kamada's revenue was $31.47 million.
What was KMDA's revenue growth in the past year?
As of Q1 2023, Kamada's revenue has grown 24.79% year over year. This is 242.09 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 266.89%. Kamada's revenue in the past year totalled $129.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.